AN2 Therapeutics • ANTX
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Eric Easom$78.7M
Market Cap • 25/07/20242017
(há 7 anos)
2022
(2 years ago)
NASDAQ
Listagem
Menlo Park
Sede • California36
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ANTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.